Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Viva Biotech

Founders Cheney Mao

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$17M
Portfolio companies 6
Rounds per year 0.47
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Artificial Intelligence
  • Therapeutics
  • Medical
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Viva Biotech:
Typical Co-investors
Viva Biotech is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Viva Biotech:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
21st Century Internet Venture Partners California, San Francisco, United States
Aetna Ventures Connecticut, Hartford, United States
Almoayed Ventures Bahrain, Capital Governorate, Manama
AtlasInvest Belgium, Brussels, Brussels Hoofdstedelijk Gewest
Beijing Chunfeng Wanhua Touzi Guanli Youxian Gongsi Beijing, China, Haidian
Counterpart Advisors California, Manhattan Beach, United States
CREATE Partners Cambridge, Cambridgeshire, United Kingdom
Dimension Japan, Tokyo
Frontier Ventures California, Cupertino, United States
Fujisawa Investments for Entrepreneurship Evanston, Illinois, United States
Gallatin Point Capital Connecticut, Greenwich, United States
Kajima Corp Chiba Prefecture, Japan, Tateyama
lastminute.com group Chiasso, Switzerland, Ticino
Media Camp Burbank, California, United States
Middleton Enterprises Newcastle upon Tyne, North East, United Kingdom
Monestier Capital -
Nike Accelerator Beaverton, Oregon, United States
PS Alliance Kyonggi-do, Seongnam, South Korea
Quilvest Private Equity France, Ile-de-France, Paris
Uberis Capital Cambodia, Phnom Penh

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Totient

Artificial Intelligence
Biotechnology
Life Science
Machine Learning
$10M10 Sep 2020 Cambridge, Massachusetts, United States

Triumvira Immunologics

Biotechnology
Clinical Trials
Health Care
$55M27 Aug 2020 Austin, Texas, United States

Regenacy Pharmaceuticals

Biotechnology
Medical
Therapeutics
$30M25 Mar 2020 Massachusetts, United States

DTx Pharma

Biotechnology
Therapeutics
$10M06 Jan 2020 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Viva Biotech?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 17M
Rounds per year 0.47
Peak activity year 2020
Lead investments 2
Follow on index 0.14
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Totient

Artificial Intelligence
Biotechnology
Life Science
Machine Learning
$10M10 Sep 2020 Cambridge, Massachusetts, United States

Triumvira Immunologics

Biotechnology
Clinical Trials
Health Care
$55M27 Aug 2020 Austin, Texas, United States

Regenacy Pharmaceuticals

Biotechnology
Medical
Therapeutics
$30M25 Mar 2020 Massachusetts, United States

DTx Pharma

Biotechnology
Therapeutics
$10M06 Jan 2020 San Diego, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: